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There has been a sustained increase in preterm 
delivery (< 37 weeks gestation) and small-for-
gestational-age (SGA; defined as birth weight 
below the 10th percentile for a given sex and 
gestational week) prevalence in the United 
States in the last few decades. This is a cause of 
concern because these conditions are associated 
with increased risks of infant morbidity and 
mortality, as well as health problems in later 
life (Behrman and Butler 2007). Numerous 
studies have attempted to determine whether 
environmental exposures, such as consump-
tion of contaminated drinking water during 
pregnancy, play a role in the observed increase 
in preterm delivery and SGA prevalence. Most 
of these studies have focused on water disinfec-
tion by-products (e.g., Hoffman et al. 2008a, 
2008b; Joyce et al. 2008; Lewis et al. 2007; 
Yang 2004; Yang et al. 2007). In contrast, only 
a handful have focused on other water contami-
nants, such as pesticides (Bukowski et al. 2001; 
Munger et al. 1997; Villanueva et al. 2005).
In many areas of theU.S. Midwest, the 
landscape is dominated by agricultural crops 
routinely treated with various pesticides. In 
Indiana, approximately 21–27% of the total 
area is planted each year with corn [U.S. 
Department of Agriculture (USDA) 2007], 
and more than 85% of this area is treated with 
the herbicide atrazine (6-chloro-N2-ethyl-
N4-isopropyl-1,3,5-triazine-2,4-diamine) 
(CropLife Foundation 2006). As a conse-
quence, many community water systems 
(CWSs) distribute finished drinking water 
containing atrazine (Hua et al. 2006; McMillin 
and Means 1996). At least during spring and 
summer, concentrations of this herbicide are 
significant, and exceedances of the federal max-
imum contaminant level (MCL) of 3.0 µg/L 
(U.S. Environmental Protection Agency (EPA) 
2003) are common.
To date, there have been only two studies 
relating concentrations of atrazine in drink-
ing water and adverse pregnancy outcomes. 
Munger et al. (1997) reported that the per-
centage of SGA babies was higher in Iowa 
communities with a mean annual atrazine con-
centration of > 2.2 µg/L compared with com-
munities with < 0.8 µg/L atrazine. However, 
this study did not control for the fact that 
atrazine concentrations vary widely through-
out the year within the same water source. 
Villanueva et al. (2005) found no association 
between atrazine concentrations in drinking 
water in French communities and prevalence 
of SGA, prematurity, or low birth weight. 
However, this lack of association might have 
been attributable to differences in concentra-
tions between unexposed and exposed groups 
that were rather small (< 0.029 µg/L in the 
control group and > 0.036 µg/L in the high 
exposure group).
Our objective was to test the potential 
association between atrazine concentrations in 
drinking water during different periods of the 
pregnancy and prevalence of preterm deliv-
ery and SGA. We hypothesized that preterm 
delivery may be related to exposures occur-
ring during early pregnancy, because develop-
mental abnormalities, which have been shown 
to increase the risk of preterm delivery, occur 
during the first weeks of pregnancy (Dolan 
et al. 2007). We also hypothesized that pre-
term delivery may alternatively be caused by 
a direct effect on the mother, prompting early 
labor, which is likely to be triggered by events 
occurring shortly before delivery. We fur-
ther hypothesized that effects on intrauterine 
growth may be related to exposures occurring 
during the last trimester or during the entire 
pregnancy. We based this study on a detailed 
atrazine concentrations data set developed over 
the years as part of several monitoring efforts 
and the spatial demarcation of CWS service 
area boundaries. These data were used to esti-
mate the drinking-water exposure to atrazine 
of mothers living within these service areas. 
Materials and Methods 
Exposure concentrations. We selected CWSs 
that obtained their water from a surface water 
source, that served urban areas, and for which 
there was certainty about the boundaries 
of the CWS service area. We selected these 
CWSs to allow unequivocal assignment of 
birth records to CWSs using the geographic 
coordinates of each mother’s residence. For 
all but two CWSs, boundaries were ascer-
tained from the 2000 census of populated 
areas that were part of a CWS, based on 
information from the Indiana Department of 
Environmental Management (IDEM) [U.S. 
Department of Commerce (USDOC) 2008]. 
In the case of Bloomington CWS, service 
area boundaries were ascertained based on 
digital map layers of the surface water dis-
trict boundary provided by the CWS. For 
one CWS (Stucker Fork), boundaries were 
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delineated based on scanning and digitizing 
a paper map of water pipelines and a hand-
drawn, 0.5-mile buffer around them. After all 
CWS boundaries were completed, the infor-
mation was compiled into one ArcGIS shape-
file (version 9.2; ESRI, Redlands, CA). 
Pesticide concentrations in drinking water 
are not regularly collected by any agency, 
except for the quarterly samples required of all 
public water systems under the Safe Drinking 
Water Act (1974). This temporal resolution is 
not sufficient for resolving short-term exposures 
or even reconstructing cumulative exposure 
during the entire pregnancy. We had access to 
three additional data sets of atrazine concentra-
tions in finished drinking water in Indiana, 
each of which contained records from biweekly 
sampling for periods of several months to sev-
eral years. These data were collected as part 
of the Acetochlor Registration Partnership 
(Hackett et al. 2005), Novartis Atrazine Public 
Water System Voluntary Monitoring (Tierney 
et al. 1999), and the Atrazine and Simazine 
Re-registration Program (U.S. EPA 2006). 
Combined with the data from IDEM (Safe 
Drinking Water Act samples), atrazine con-
centrations in finished drinking water could be 
reconstructed for surface drinking water sys-
tems between 1993 and 2007. The Acetochlor 
Registration Partnership took place from 
1995 to 2001. Acetochlor, alachlor, atrazine, 
and metolachlor were included in this study 
(Hackett et al. 2005). The Novartis Atrazine 
Public Water System Voluntary Monitoring 
Program measured atrazine and simazine con-
centrations from 1993 to 1996 (Tierney et al. 
1999). Finally, Syngenta began the Atrazine 
Monitoring Program in 2003, which focused 
on atrazine concentrations (U.S. EPA 2006). 
All these monitoring efforts sampled atrazine 
in drinking water every 7–14 days during the 
spring/summer and less often during the rest 
of the year. From these data sets, we selected 
sampling periods when sampling occurred at 
least biweekly during the spring and summer 
and where at least two samples were collected 
and analyzed during fall and winter. In the case 
of Bloomington, we obviated this requirement 
because this CWS has had atrazine concentra-
tions consistently below the detection limit 
and therefore was not the object of intense 
sampling. 
Pregnancy outcomes. Infant and mother 
information was retrieved from the Indiana 
Birth Records Database. This database con-
tains > 100 variables describing demographic 
characteristics of the mother, her health, health 
attitudes, pregnancy outcomes, procedures 
performed before and during delivery, and 
the geographic coordinates of the mother’s 
domicile for all babies delivered in Indiana. 
The Institutional Review Board of Purdue 
University and the Indiana State Department 
of Health approved the study protocol using 
the selected records. Birth locations were 
matched to specific CWSs by using the lati-
tude and longitude coordinates of the moth-
er’s domicile location at the time of birth. To 
ensure balanced representation of all periods 
throughout the annual cycle, and to properly 
reconstruct concentrations for the entire preg-
nancy, we selected for each CWS pregnancies 
occurring when continuous atrazine concen-
tration records were available for whole years, 
and for which atrazine concentrations were 
available for the entire pregnancy. The result 
of this selection was that although births were 
selected from all the CWSs included in the 
study, the number of births from each CWS 
varied greatly, with most records coming from 
Ft. Wayne. We determined gestation length 
based on the date of the last menses or on 
the gestation length in weeks reported in the 
registry. We excluded records from multiple 
pregnancies or terminated by cesarean section 
or by induction of labor. We also excluded 
records with gestation lengths < 22 weeks 
or > 44 weeks, given that births < 22 weeks 
are rarely viable and that births are usually 
induced before the 44th week of gestation. 
Finally, we also excluded birth weights < 200 g 
and > 6,000 g, because these weights are likely 
the result of misreporting. Births were consid-
ered preterm if they occurred before the 37th 
week of pregnancy. Babies were considered 
SGA if their weight at birth was below the 
10th percentile of birth weights for their sex at 
the given gestation week, based on data from 
more than 6 million singleton births occurring 
during 1999–2000 in the United States (Oken 
et al. 2003).
Data analysis. We created continuous 
atrazine concentration time series for each 
CWS by linear interpolation between sam-
pling dates using PROC EXPAND (version 
9.1; SAS Institute Inc., Cary, NC, USA). 
Then, depending on the birth date and length 
of gestation, we calculated the average atrazine 
concentrations for the first and last month of 
pregnancy and for the entire pregnancy. We 
aimed at determining the association between 
atrazine concentrations during the first and 
last month of pregnancy and preterm delivery 
and pregnancy duration. For SGA and term 
birth weight, we focused on the average atra-
zine concentration during the last trimester 
for term births and the entire pregnancy for all 
births. For each pregnancy period studied, we 
divided birth records into low, medium, and 
high groups according to the concentration of 
atrazine in drinking water. We used the 25th 
and 75th percentiles as cutoffs. Measures of 
association were also estimated using atrazine 
concentrations as continuous measures.
Association between atrazine concentra-
tions and the response variables was studied 
using a two-step process. First, we ran log-
binomial models using PROC GENMOD 
(SAS Institute Inc.) to identify potential con-
founders to be included in the final models. 
Confounders considered included infant’s sex 
and mother’s ethnicity, age, marital status, 
education, prenatal care, previous reproduc-
tive history, health status during pregnancy, 
and smoking, drinking, and drug use. In 
addition to these variables, we also included 
the quarter of the year in which conception 
occurred to account for any seasonal dif-
ference in preterm births and SGA and the 
known seasonal trends observed for atrazine 
concentrations in drinking water (Figure 1). 
Confounders were dropped if they did not 
cause a > 1.0% change in the prevalence ratio 
(PR) of the atrazine level variable compared 
with the fully parameterized model and if 
their level of significance was < 0.1. PRs and 
their respective 95% confidence intervals (CIs) 
were then estimated by fitting the final log-
binomial models using PROC GENMOD 
ESTIMATE option. Duration of pregnancy 
in weeks and term birth weights (≥ 37 weeks) 
were also fitted to linear models that included 
atrazine concentrations and confounders as 
explanatory variables. In the case of term birth 
weights, we also included gestation length in 
weeks and its quadratic term in the models 
to account for growth leveling off toward the 
end of pregnancy (Ritz and Yu 1999). 
Results 
Drinking-water atrazine concentration data 
are summarized in Table 1 for each CWS. 
Atrazine tended to decrease to below detection 
levels in the winter months in all CWSs (data 
not shown). Although median annual con-
centrations were similar among several CWSs 
(Evansville, Ft. Wayne, Richmond, Jasper), 
maximum values, as well as the number of 
days atrazine concentrations exceeded 0.2 and 
0.5 µg/L, varied greatly among CWSs. A total 
of 24,154 birth records were linked to atrazine 
and included in this study. The number of 
births varied among CWSs because of differ-
ent population size and number of years with 
adequate atrazine data. Most birth records 
(67.8%) were from one CWS, Ft. Wayne. 
Figure 1. Seasonal pattern of atrazine concen-
trations in finished drinking water in Ft. Wayne, 
Indiana, USA. Dots indicate mean, lines median, 
boxes the interquartile range (25th–75th percen-
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Preterm delivery and pregnancy dura-
tion. Maternal characteristics for the preterm 
and SGA prevalence studies are presented in 
Table 2. Overall, prevalence of preterm deliv-
ery was 7.36% (95% CI, 7.18–7.54). Preterm 
delivery was more prevalent for male, com-
pared with female, babies and for babies born 
to unmarried mothers (Table 2). Preterm 
delivery prevalence decreased with maternal 
age until 26–28 years and then increased. 
African-American and Native-American 
mothers had higher preterm delivery prev-
alence than white (including Hispanic) or 
Asian-American mothers; Hispanic mothers 
had lower prevalence than non-Hispanics. 
We also observed that prevalence varied with 
parity, with the lowest rate for the second 
birth. Mothers with a history of a previous 
infant death or of fetal death had preterm 
prevalence almost twice as high as the overall 
value. Preterm delivery prevalence decreased 
with increasing level of education attained by 
the mother and mothers commencing prena-
tal care during the first month of pregnancy 
had lower prevalence than the overall value. 
Mothers who self-reported smoking, drinking, 
and drug use during pregnancy had higher 
rates of preterm delivery than mothers not 
reporting these behaviors. Mothers suffering 
from a concurrent disease during pregnancy 
had higher prevalence than healthy mothers.
Results from our analysis comparing 
groups of mothers exposed to different lev-
els of atrazine in drinking water showed that 
prevalence of preterm delivery was not signifi-
cantly associated with atrazine during the first 
or last months of pregnancy when adjusting 
for potential confounders (Table 3). 
The overall average duration of pregnancy 
was 38.8 ± 2.11 weeks. Our analysis on the 
prevalence of preterm delivery found that when 
atrazine was included in the model as a con-
tinuous variable, it was not significantly associ-
ated with preterm delivery after controlling for 
known confounders (adjusted PR = 1.07; 95% 
CI, 0.99–1.15). In addition, atrazine concen-
tration during the last month of pregnancy was 
not significantly associated with prevalence of 
preterm delivery when considered as a continu-
ous variable (PR = 0.99; 95% CI, 0.92–1.06).
SGA and term birth weight. The prevalence 
of SGA was 13.13% (95% CI, 12.95–13.31) 
(Table 2). Male babies had a higher prevalence 
of SGA than female babies, and unmarried 
mothers had a higher prevalence of SGA than 
married ones. Prevalence of SGA decreased with 
maternal age and was higher in black and Asian-
American mothers compared with white moth-
ers. We also found that the second child from 
a mother had the lowest prevalence of SGA 
and that mothers with a previous fetal death or 
live-born infant dying after birth had a higher 
prevalence of SGA. Prevalence of SGA also 
decreased with maternal education, and moth-
ers who started prenatal care during the first 
month of pregnancy had lower SGA prevalence. 
Prevalence of SGA increased with self-reported 
use of tobacco, alcohol, and drug during preg-
nancy, and mothers who were ill during preg-
nancy also had elevated SGA prevalence.
When using mean atrazine concentration 
during the third trimester of pregnancy as the 
exposure metric for term babies, we found that 
prevalence of SGA increased from 11.0% in 
the reference group (i.e., < 25th percentile, or 
0.103 µg/L atrazine) to 14.3% for medium 
and 13.1% for the high atrazine group. 
Prevalence of SGA in the medium and high 
atrazine groups were increased by 19 and 17%, 
respectively (Table 3). We also found that the 
(log-transformed) mean atrazine concentration 
during the third trimester was associated with 
an increase in the prevalence of SGA (adjusted 
PR = 1.12; 95% CI, 1.07–1.17). Term (≥ 37 
weeks) birth weight in the study population 
was 3,338 ± 457 g (mean ± SE). Atrazine con-
centrations during the third trimester were also 
significantly associated with a decrease in term 
birth weight (p = 0.0011) after controlling for 
potential confounders using linear models that 
also included gestational duration.
In the case of exposures quantified as the 
mean atrazine concentration over the entire 
pregnancy, prevalence of SGA increased from 
12.0% in the reference group (i.e., < 25th 
percentile, or 0.179 µg/L atrazine for the 
entire pregnancy) to 13.3% for medium and 
13.9% for the high atrazine group. Prevalence 
of SGA in the high atrazine group was 14% 
higher than in the control group (adjusted 
PR = 1.14; 95% CI, 1.03–1.24). We also 
found that the prevalence of SGA was signifi-
cantly associated with atrazine when this was 
included as a continuous variable in the mod-
els (adjusted PR = 1.15; 95% CI, 1.04–1.28). 
A 1.0-µg/L increase in mean atrazine concen-
tration in drinking water for the entire preg-
nancy was associated with an average increase 
of 15% in the prevalence of SGA. We found 
that mean atrazine concentrations in drink-
ing water over the entire pregnancy were also 
significantly associated with a decrease in term 
birth weight. We found that birth weight 
decreased by 34.06 ± 10.7 g (mean ± SE) for 
every additional microgram per liter of atra-
zine in drinking water (p = 0.0015). We also 
found that when restricting our analysis to Ft. 
Wayne, which included most of the observa-
tions of the study, the analysis resulted in a 
similar trend, with the highest exposure group 
Table 1. Summary of atrazine data for Indiana CWSs included in the study.
No. of No. of Atrazine concentrationsb 
Mean (± SD) no. of days 
atrazine Preterm prevalence SGA prevalence
CWS yearsa births  Annual median Annual maximum > 0.2 µg/L > 0.5 µg/L (95% CI)c (95% CI)c
Batesville 7 233 0.996 ± 0.278 1.988 ± 0.774 18 ± 13 15 ± 10 7.30 (6.85–7.74) 6.01 (5.64–6.38)
Bedford 4 255 0.101 ± 0.124 5.282 ± 7.643   7 ± 11 4 ± 7 8.24 (7.76–8.71) 8.24 (7.76–8.71)
Bloomington 9 1,849 0.058 ± 0.170 0.096 ± 0.207 11 ± 30 0 6.60 (6.45–6.74) 8.49 (8.31–8.67)
Dubois 3 134 0.080 ± 0.026 0.110 ± 0.039 0 0 9.70 (8.94–10.5) 9.70 (8.94–10.5)
Evansville 4 2,296 0.158 ± 0.073 0.987 ± 0.265 63 ± 60 26 ± 28 6.79 (6.66–6.93) 14.1 (13.8–14.3)
Ft. Wayne 9 16,393 0.194 ± 0.090 4.290 ± 2.108 265 ± 218 129 ± 100 7.58 (7.52–7.63) 13.7 (13.6–13.8)
Indiana American Northwest 1 692 0.001 0.001 0 0 3.90 (3.76–4.04) 12.9 (12.4–13.3)
Indiana American Kokomo 1 59 0.305 0.856 106 ± 149 13 ± 18 11.9 (10.5–13.2) 5.08 (4.46–5.71)
Indiana American Richmond 2 324 0.261 ± 0.071 0.490 ± 0.014 0 0 12.3 (11.7–12.9) 12.3 (11.7–12.9)
Jasper 8 280 0.214 ± 0.098 2.623 ± 2.882 12 ± 12 5 ± 6 7.14 (6.75–7.54) 8.21 (7.76–8.66)
Logansport 2 216 0.120 ± 0.087 5.936 ± 8.069 17 ± 28   6 ± 10 6.48 (6.07–6.89) 13.9 (13.1–14.7)
Michigan City 3 848 0.011 ± 0.008 0.028 ± 0.017 0 0 7.19 (6.96–7.42) 17.0 (16.5–17.5)
Mitchell 3 64 0.066 ± 0.061 1.045 ± 1.700 2 ± 4 2 ± 4 9.38 (8.31–10.4) 9.38 (8.31–10.4)
Mt. Vernon 3 90 0.087 ± 0.032 0.965 ± 0.636 4 ± 3 2 ± 3 — 6.67 (6.01–7.32)
Northwest Indiana 1 165 0.001 0.001 0 0 5.45 (5.05–5.86) 14.5 (13.6–15.5)
Oakland City 3 22 0.154 ± 0.063 0.193 ± 0.086 0 0 9.09 (7.33–10.9) —
Salem 4 100 0.294 ± 0.338 0.604 ± 0.506 6 ± 8 0 5.00 (4.53–5.48) 12.0 (10.9–13.1)
Scottsburg 4 65 0.435 ± 0.535 0.647 ± 0.549 4 ± 6 2 ± 3 9.23 (8.19–10.3) 10.8 (9.58–12.0)
Stucker Fork 4 69 0.094 ± 0.083 3.379 ± 4.096 3 ± 3 0 8.70 (7.74–9.65) 18.8 (17.0–20.7)
—, no data.
aIncludes only years with complete atrazine time series. bValues represent the mean of annual median and maximum concentrations. cPrevalence values in percentage (per 100). Ochoa-Acuña et al.
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(> 0.742 µg/L) having an 11% increase in the 
prevalence of SGA (adjusted PR = 1.11; 95% 
CI, 1.00–1.24) compared with the lowest 
exposure group (< 0.320 µg/L).
Discussion 
The results of this study suggest that prena-
tal exposure to atrazine in drinking water is 
associated with reduced birth weight, but 
not preterm delivery. Only two previous 
studies have looked at the potential associa-
tion between atrazine in drinking water and 
adverse pregnancy outcomes (Munger et al. 
Table 2. Total number of births and cases and prevalence of preterm delivery and SGA births by characteristics of the mother.
Preterm delivery SGA 
Variable
No. of births 
or mean ± SD
No. of cases 
or mean ± SD Prevalence (95% CI)
No. of births 
or mean ± SD 
No. of cases 
or mean ± SD  Prevalence (95% CI)
All records 24,154 1,777 7.36 (7.18–7.54) 24,154 3,172 13.1 (12.9–13.3)
Mean gestational age (weeks) 39.23 ± 1.12 33.96 ± 3.13 38.85 ± 1.99 38.79 ± 1.64
Mean birth weight (g) 3,338 ± 457 2,367 ± 731 3,367 ± 501 2,604 ± 309
SGA (< 10th percentile) 3,172 230 7.25 (7.13–7.37)
Preterm (< 37 weeks) 1,777 230 12.9 (12.7–13.2)
Sex of infant
  Female 11,984 799 6.67 (6.61–6.72) 11,984 1,476 12.3 (12.2–12.4)
  Male 12,170 978 8.04 (7.97–8.10) 12,170 1,696 13.9 (13.8–14.0)
Baby conceived during      
  First quarter of year 5,456 414 7.59 (7.49–7.68) 5,456 720 13.2 (13.0–13.3)
  Second quarter of year 5,754 430 7.47 (7.38–7.56) 5,754 801 13.9 (13.8–14.1)
  Third quarter of year 6,346 453 7.14 (7.06–7.22) 6,346 797 12.6 (12.4–12.7)
  Fourth quarter of year 6,598 480 7.27 (7.19–7.36) 6,598 854 12.9 (12.8–13.1)
Marital status
  Married 12,710 794 6.25 (6.20–6.30) 12,710 1,165 9.17 (9.09–9.24)
  Unmarried 11,443 983 8.59 (8.52–8.66) 11,443 2,006 17.5 (17.4–17.7)
Maternal age (years)
  < 22 7,287 634 8.70 (8.61–8.79) 7,287 1,247 17.1 (16.9–17.2)
  22–25 6,226 439 7.05 (6.97–7.13) 6,226 833 13.4 (13.2–13.5)
  26–28 3,874 238 6.14 (6.05–6.24) 3,874 418 10.8 (10.6–10.9)
  29–32 3,855 260 6.74 (6.64–6.85) 3,855 377 9.78 (9.64–9.92)
  > 32 2,912 206 7.07 (6.95–7.20) 2,912 297 10.2 (10.0–10.4)
Maternal race
  African American 4,599 451 9.81 (9.68–9.94) 4,599 974 21.2 (20.9–21.4)
  Asian/Pacific islander 200 14 7.00 (6.54–7.46) 200 30 15.0 (14.1–15.9)
  Native American 42 7 16.7 (14.5–18.8) 42 1 2.38 (2.02–2.74)
  Whitea 18,770 1,268 6.76 (6.71–6.80) 18,770 2,087 11.1 (11.0–11.2)
  Other 454 28 6.17 (5.90–6.44) 454 70 15.4 (14.8–16.0)
Ethnicity
  Hispanic origin 1,969 126 6.40 (6.26–6.53) 1,969 250 12.7 (12.4–12.9)
  Non-Hispanic 22,185 1,651 7.44 (7.40–7.49) 22,185 2,922 13.2 (13.1–13.2)
Parity
  First birth 9,510 793 8.34 (8.26–8.42) 9,510 1,458 15.3 (15.2–15.5)
  Second birth 7,567 478 6.32 (6.25–6.38) 7,567 841 11.1 (11.0–11.2)
  Third or subsequent birth 7,047 502 7.12 (7.04–7.20) 7,047 868 12.3 (12.2–12.4)
Previous infant deaths 392 50 12.8 (12.2–13.3) 392 51 13.0 (12.4–13.6)
Previous fetal deaths (≥ 1) 31 4 12.9 (10.9–14.9) 31 9 29.0 (25.3–32.7)
Maternal education
  < High school 6,379 562 8.81 (8.71–8.91) 6,379 1,197 18.8 (18.6–19.0)
  High school 8,510 638 7.50 (7.42–7.57) 8,510 1,202 14.1 (14.0–14.3)
  Some college 5,077 360 7.09 (7.00–7.18) 5,077 512 10.1 (10.0–10.2)
  4-year college 4,188 217 5.18 (5.11–5.26) 4,188 261 6.23 (6.14–6.32)
Month prenatal care began
  1st 3,553 216 6.08 (5.98–6.18) 3,553 366 10.3 (10.1–10.5)
  2nd 8,272 593 7.17 (7.1–7.24) 8,272 1,004 12.1 (12.0–12.2)
  3rd 6,352 447 7.04 (6.96–7.12) 6,352 805 12.7 (12.5–12.8)
  > 3rd 5,233 398 7.61 (7.51–7.70) 5,233 847 16.2 (16.0–16.4)
Not a WIC participant 12,583 846 6.72 (6.67–6.78) 12,583 1,252 9.90 (9.87–10.0)
WIC participant 11,569 930 8.04 (7.97–8.11) 11,569 1,920 16.6 (16.5–16.7)
Maternal smoking 
  Did not smoke 18,662 1,286 6.89 (6.84–6.94) 18,662 2,018 10.8 (10.7–10.9)
  Smoked 1–5 cigarettes/day 1,336 110 8.23 (8.03–8.44) 1,336 265 19.8 (19.4–20.3)
  Smoked 6–9 cigarettes/day 789 75 9.51 (9.20–9.81) 789 152 19.3 (18.7–19.8)
  Smoked 10–19 cigarettes/day 2,044 180 8.81 (8.63–8.98) 2,044 414 20.2 (19.9–20.6)
  Smoked 20–29 cigarettes/day 1,061 95 8.95 (8.70–9.20) 1,061 260 24.5 (23.9–25.1)
  Smoked > 29 cigarettes/day 191 22 11.5 (10.8–12.3) 191 47 24.6 (23.3–25.9)
Mother did not drink during pregnancy 23,837 1,742 7.31 (7.26–7.35) 23,837 3,097 13.0 (12.9–13.1)
Mother drank during pregnancy 207 21 10.1 (9.51–10.8) 207 51 24.6 (23.3–25.9)
Mother did not used drugs during pregnancy 23,771 1,710 7.19 (7.15–7.24) 23,771 3,065 12.9 (12.8–13.0)
Mother used drugs during pregnancy 309 59 19.1 (18.2–20.0) 309 96 31.1 (29.8–32.3)
Mother was not ill during pregnancy 19,574 1,366 6.98 (6.93–7.03) 19,574 2,531 12.9 (12.8–13.0)
Mother was ill during pregnancy 4,580 411 8.97 (8.85–9.09) 4,580 641 14.0 (13.8–14.2)
WIC, Special Supplemental Nutrition Program for Women, Infants, and Children.
aIncludes Caucasians of Hispanic origin. Herbicides and adverse pregnancy outcomes
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1997; Villanueva et al. 2005). The Munger 
et al. (1997) study was based on comparing 
prevalence of SGA of 13 communities served 
by a CWS with high levels of atrazine with 
mothers living in communities of different 
size and from the same counties. This study 
reported that atrazine and other herbicide con-
centrations were significant predictors of com-
munity prevalence of SGA but not preterm 
delivery. However, this ecologic study did 
not attempt to control for seasonal changes 
in atrazine concentrations and lacked proper 
control of individual-level potential confound-
ers. The Villanueva et al. (2005) study was 
based on assigning birth records to different 
exposure levels estimated as the overall mean 
of atrazine concentrations measured over an 
8-year period, irrespective of when each preg-
nancy occurred. This study did not detect 
an association between atrazine in drinking 
water and prevalence of preterm delivery, low 
birth weight, or SGA. Villanueva at al. (2005) 
hypothesized that this lack of association may 
have been due to the fact that exposure con-
centrations were relatively low, with cutoff 
values for the medium and high exposure 
groups of 0.029 and 0.036 µg/L, respectively 
(Villanueva et al. 2005). In the case of Munger 
et al. (1997), exposed and unexposed commu-
nities had a mean atrazine concentration of 
2.2 and 0.7 µg/L, respectively.
The observed association may not repre-
sent an effect due to exposure solely to atra-
zine, but rather also to other co-occurring 
chemicals. We had access to finished drinking-
water concentration data for other herbicides 
collected from a small subset of the samples 
used in this study. The herbicides acetochlor, 
alachlor, and metolachlor were all correlated 
with atrazine (correlation coefficients, r = 
0.65, 0.54, and 0.84, respectively). However, 
these herbicides were detected much less 
frequently than atrazine and at significantly 
lower concentrations. Hackett et al. (2005) 
reported that the occurrence of annualized 
mean concentrations of acetochlor, alachlor, 
and metolachlor exceeding 0.1 µg/L in fin-
ished drinking water was 8.1, 2.9, and 2.2%, 
respectively. In contrast, atrazine concentra-
tions exceeded 0.1 µg/L 74.4% of the time. 
The extent to which this study demonstrates 
an association between adverse pregnancy out-
comes and atrazine or, alternatively, herbicides 
in general, cannot be ascertained at this time. 
A significant source of uncertainty in 
studies that use drinking-water concentra-
tion as the exposure metric is that the level 
of municipal, unfiltered water consumption 
of individual subjects is unknown. Pregnant 
women may choose to use bottled water over 
tap water, at least for some proportion of their 
water needs. Forssen et al. (2007) found that 
of 2,300 women, 28% used bottled water 
and 19% used filtered tap water. This is an 
increase from a 2001 study of 114 women, 
which showed that 25% drank bottled or fil-
tered water (Zender et al. 2001). Women who 
work outside of the home or travel may also 
be exposed to alternative water supplies. More 
than 30% of water consumption for pregnant 
women occurred outside of the home (Kaur 
et al. 2004). We have no information for our 
study population regarding the level of use 
of tap water or whether the same level of use 
exists for different CWSs or times of the year.
A potential source of misclassification in 
spatial epidemiologic studies results from the 
address at birth not representing the address 
at conception, either through incorrect data or 
if the subject moved between conception and 
delivery. Many studies that evaluated birth 
events used the address of the mother at the 
time of birth, as found on the birth certificate. 
Using the address given at the time of deliv-
ery may introduce misclassification to stud-
ies on the association between health effects 
and maternal environmental exposure dur-
ing pregnancy (Fell et al. 2004; Shaw et al. 
1999). Mobility rates for pregnant women 
have varied among studies, from 12% (Fell 
et al. 2004), 20% (Khoury et al. 1988), and 
25% (Shaw et al. 1999) to 32% (Zender et al. 
2001). Although these data suggest a poten-
tial concern for relating drinking water to 
health outcomes, 62–69% of the women who 
moved did so within the same county or water 
municipality in these study populations (Fell 
et al. 2004; Shaw et al. 1999). Unfortunately, 
no estimates of maternal residential mobility 
during pregnancy exist for the state of Indiana.
A major strength of the present study 
is the ability to control for several potential 
confounding factors. The effects and mater-
nal confounder data used in this study were 
retrieved from the Indiana State Department 
of Health Birth Certificates database. This 
database contains information entered by 
hand from hospital records, so there is a 
chance of incorrect data entry. However, a 
study (Zollinger et al. 2006) conducted to 
assess the accuracy and completeness of this 
database compared with hospital records 
found that important descriptive and outcome 
data variables were reliable, whereas data for 
infrequent events were not. There was good 
agreement in the case of birth weight and 
prematurity as well as for demographic data, 
and moderate agreement among behavioral 
risk factors (Zollinger et al. 2006). However, 
we were not able to determine whether bias 
was introduced by incorrect determination of 
gestational length or untruthful self-reporting 
of behavioral risk factors, such as smoking and 
alcohol and drug use by the mother.
Our data set included a wide array of 
CWSs that had different temporal profiles 
of atrazine concentrations in drinking water. 
Although all CWSs where atrazine was rou-
tinely detected tended to have very low con-
centrations during the winter months, the 
magnitude and duration of concentration peaks 
varied among CWSs. A potential problem with 
Table 3. Prevalence of preterm delivery and SGA in relation to mean level of atrazine in drinking water (µg/L) and adjusted PRs (95% CI) for comparisons between 
medium (≥ 25th, ≤ 75th percentiles), and high (> 75th percentile) and the control exposure group (< 25th percentile).
Atrazine exposure Within-group percentiles No. of
Gestation length 
(weeks ± SD) or
No. of  
preterm/ Preterm/SGA Preterm/SGA
Response group (µg/L)a 25th 50th 75th births birth weight (g ± SD) SFA cases prevalence  (CI) adjusted PR (CI)b
Preterm delivery
  First month < 0.057 0.001 0.020 0.050 4,995 38.9 ± 2.02 358 7.17 (7.07–7.26)
0.057 to 0.435 0.100 0.165 0.256 10,072 38.8 ± 1.95 736 7.31 (7.24–7.37) 0.98 (0.87–1.11)
> 0.435 0.655 1.121 1.781 5,034 38.8 ± 1.96 402 7.99 (7.88–8.09) 1.07 (0.93–1.22)
  Last month < 0.057 0.001 0.037 0.050 5,407 38.9 ± 2.00 393 7.27 (7.18–7.36)
0.057–0.507 0.100 0.180 0.281 10,889 38.8 ± 1.96 818 7.51 (7.45–7.58) 1.04 (0.93–1.18)
> 0.507 0.768 1.227 1.884 5,443 38.8 ± 1.95 409 7.51 (7.42–7.61) 0.87 (0.72–1.04)
SGA
  Third trimesterc  < 0.103 0.001 0.045 0.050 4,363 3,309 ± 528 479 11.0 (10.8–11.1)
0.103–0.835 0.117 0.210 0.326 8,747 3,268 ± 526 1,251 14.3 (14.2–14.4) 1.19 (1.08–1.32)
> 0.835 0.872 1.116 1.482 4,373 3,276 ± 514 575 13.1 (13.0–13.3) 1.17 (1.03–1.34)
  Entire pregnancy < 0.179 0.001 0.047 0.107 6,038 3,284 ± 568 723 12.0 (11.8–12.1)
0.179–0.644 0.277 0.363 0.491 12,078 3,273 ± 534 1,609 13.3 (13.2–13.4) 1.06 (0.98–1.15)
> 0.644 0.740 0.822 0.950 6,038 3,237 ± 543 840 13.9 (13.8–14.1) 1.14 (1.03–1.24)
aValues listed correspond to < 25th, 25th–75th, and > 75th percentiles. bAdjusted for mother’s ethnicity, level of education, month prenatal care began, smoking status, and quarter of 
the year in which baby was conceived. cExcludes records from preterm deliveries (< 37 weeks’ gestation).Ochoa-Acuña et al.
1624  v o l u m e  117 | n u m b e r 10 | October 2009  •  Environmental Health Perspectives
these data is that other, uncontrolled differ-
ences among CWSs may have contributed to 
the observed association between atrazine and 
adverse pregnancy outcomes. We evaluated 
this possibility by restricting our analysis to Ft. 
Wayne, which included most of the observa-
tions of the study. This reduced the difference 
in atrazine concentrations among exposure 
groups. Nevertheless, the analysis of Ft. Wayne 
resulted in a similar trend, with the highest 
exposure group (> 0.742 µg/L) for the entire 
pregnancy having an 11% increase in the prev-
alence of SGA (adjusted PR = 1.11; 95% CI, 
1.00–1.24) compared with the lowest exposure 
group (< 0.320 µg/L).
Unlike most other studies relating con-
centrations of chemicals in drinking water and 
adverse health effects, we had detailed atrazine 
concentrations times-series data. Although some 
exposure misclassification might have occurred 
because of extrapolation of atrazine concentra-
tions, their impact is likely small. We evaluated 
exposure based on mean values for the first and 
last months of pregnancy and for the entire 
pregnancy. Given that concentration data for 
periods of the year when atrazine concentra-
tions increase over background were collected 
every 7–14 days, it is unlikely that interpolation 
of these data resulted in significant bias. On the 
other hand, interpolation of the data to pro-
duce continuous atrazine concentration time 
series allowed for proper averaging of atrazine 
concentrations for the entire pregnancy.
The limited experimental data seem to pro-
vide biologic plausibility to the observed asso-
ciation between atrazine in drinking water and 
adverse pregnancy outcomes. Atrazine exposure 
in utero caused decreased body weight of rat 
male offspring at day 4 postpartum (Rayner 
et al. 2007). In vitro tests using murine preim-
plantation embryos showed that atrazine at con-
centrations derived from the oral reference dose 
significantly increased the level of apoptosis and 
decreased the proportion of embryos developing 
to blastocyst, both alone and in mixture with 
metolachlor, 2,4-D (2,4-dichlorophenoxyacetic 
acid), and ammonium nitrate (Greenlee et al. 
2004). However, the extent to which these data 
obtained from animal models are predictive of 
adverse effects in humans, especially of preterm 
delivery and SGA, is unknown.
In conclusion, in this study we found a 
significant association between atrazine con-
centration in drinking water and prevalence 
of SGA. However, it is not clear at present 
whether this association represents a true 
cause–effect relationship, as other co-occurring 
chemicals in drinking water were significantly 
correlated with atrazine. The large number 
of people in the Midwest who are seasonally 
exposed to these chemicals through consump-
tion and use of drinking water indicates that 
these associations be explored further.
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